miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression | Zendy

Susheng Miao | Zendy; Xionghui Mao | Zendy; Shu Zhao | Zendy; Kaibin Song | Zendy; Cheng Xiang | Zendy; Yuanjing Lv | Zendy; Huanyv Jiang | Zendy; Lei Wang | Zendy; Baojun Li | Zendy; Xianguang Yang | Zendy; Zhennan Yuan | Zendy; Xiu Cheng | Zendy; Hongxue Meng | Zendy; Ji Sun | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression

Author(s) -

Susheng Miao,

Xionghui Mao,

Shu Zhao,

Kaibin Song,

Cheng Xiang,

Yuanjing Lv,

Huanyv Jiang,

Lei Wang,

Baojun Li,

Xianguang Yang,

Zhennan Yuan,

Xiu Cheng,

Hongxue Meng,

Ji Sun

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.19121

Subject(s) - metastasis , medicine , cancer research , cancer , microrna , laryngeal neoplasm , oncology , biology , gene , genetics

High incidences of laryngeal cancer have been reported recently. Increasing our understanding of the molecular mechanisms underlying this malignancy could reveal more effective approaches to treating laryngeal cancer patients and so improve their prognoses. In this study, we explored the biological effects of miR-217 on laryngeal cancer. miR-217 potently inhibited multiple metastatic traits, including cell migration, invasion, proliferation, apoptosis, and EMT, as well as angiogensis. These effects were achieved through downregulation of the miR-217 target gene, AEG-1 and PD-L1. Clinical expression and animal model studies further confirmed our results. These findings provide new insight into the physiological effects of miR-217 in laryngeal cancer and its potential therapeutic use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research